Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece

NCT02821247 · clinicaltrials.gov ↗

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Choroidal Neovascularization
Macular Degeneration

Interventions

DRUG: Aflibercept (Eylea, BAY86-5321)

Sponsor

Bayer